Inhibitors of soluble epoxide hydrolase on acute lung injury: a meta-analysis of preclinical studies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Immunology
Link
https://link.springer.com/content/pdf/10.1007/s10787-022-01063-2.pdf
Reference24 articles.
1. Beitler JR, Thompson BT, Baron RM, Bastarache JA, Denlinger LC, Esserman L, Gong MN, LaVange LM, Lewis RJ, Marshall JC, Martin TR, McAuley DF, Meyer NJ, Moss M, Reineck LA, Rubin E, Schmidt EP, Standiford TJ, Ware LB, Wong HR, Aggarwal NR, Calfee CS (2022) Advancing precision medicine for acute respiratory distress syndrome. Lancet Respir Med 10(1):107–120. https://doi.org/10.1016/s2213-2600(21)00157-0
2. Bettaieb A, Nagata N, AbouBechara D, Chahed S, Morisseau C, Hammock BD, Haj FG (2013) Soluble epoxide hydrolase deficiency or inhibition attenuates diet-induced endoplasmic reticulum stress in liver and adipose tissue. J Biol Chem 288(20):14189–14199. https://doi.org/10.1074/jbc.M113.458414
3. Chen Z, Tang Y, Yu J, Dong R, Yang Y, Fu M, Luo J, Hu S, Wang DW, Tu L, Xu X (2020) sEH inhibitor tppu ameliorates cecal ligation and puncture-induced sepsis by regulating macrophage functions. Shock 53(6):761–771. https://doi.org/10.1097/shk.0000000000001408
4. Dong R, Hu D, Yang Y, Chen Z, Fu M, Wang DW, Xu X, Tu L (2017) EETs reduces LPS-induced hyperpermeability by targeting GRP78 mediated Src activation and subsequent Rho/ROCK signaling pathway. Oncotarget 8(31):50958–50971. https://doi.org/10.18632/oncotarget.17331
5. Ferrer MD, Busquets-Cortés C, Capó X, Tejada S, Tur JA, Pons A, Sureda A (2019) Cyclooxygenase-2 inhibitors as a therapeutic target in inflammatory diseases. Curr Med Chem 26(18):3225–3241. https://doi.org/10.2174/0929867325666180514112124
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. sEH activity is associated with mortality in patients with ARDS: a retrospective cohort study;Biomarkers in Medicine;2024-08-13
2. Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis;Frontiers in Pharmacology;2023-09-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3